Back to
UBS Asset Management Americas LLC
VKTX
27 quarters
Position history for
UBS Asset Management Americas LLC's holdings in Viking Therapeutics, Inc.
Yes. UBS Asset Management Americas holds 229,973 shares of VKTX (Viking Therapeutics), worth $9M, as of its Q2 2026 13F filing. It reduced the position by 23,921 shares (-9.4%) from Q1 2026. UBS Asset Management Americas has held VKTX since Q3 2023, across 12 quarterly 13F filings.
Current Value
$9M
Current Shares
229,973
Total Value Change
+$8.8M
Total Shares Change
+203,173
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.